Genetics of cerebral small vessel disease

Journal of Stroke

Volumn 17, Issue 1, 2015, Pages 7-16

  Choi, Jay Chol ^a  

^a Jeju National University   (South Korea)

Author keywords

CADASIL; Cerebral small vessel diseases; Fabry disease; Genetic association study; Genome wide association study

Indexed keywords

APOLIPOPROTEIN E; TUMSTATIN;

ARTERY DISEASE; AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL RECESSIVE DISORDER; CADASIL; CARASIL; CEREBROVASCULAR DISEASE; COL4A1 GENE; FABRY DISEASE; FAMILY HISTORY; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DISORDER; HERNS; HTRA1 GENE; HUMAN; LEUKODYSTROPHY; META ANALYSIS (TOPIC); MONOZYGOTIC TWINS; NEUROPATHIC PAIN; NOTCH3 GENE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84937001116     PISSN: 22876391     EISSN: 22876405     Source Type: Journal    
DOI: 10.5853/jos.2015.17.1.7     Document Type: Review

References (94)

1. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010;9:689-701.
2. White H, Boden-Albala B, Wang C, Elkind MS, Rundek T, Wright CB, et al. Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan study. Circulation 2005;111:1327-1331.
3. Sacco S, Marini C, Totaro R, Russo T, Cerone D, Carolei A. A population-based study of the incidence and prognosis of lacunar stroke. Neurology 2006;66:1335-1338.
4. Chamorro A, Sacco RL, Mohr JP, Foulkes MA, Kase CS, Tatemichi TK, et al. Clinical-computed tomographic correlations of lacunar infarction in the Stroke Data Bank. Stroke 1991;22: 175-181.
5. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O’Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke 1999;30:2513-2516.
6. Woo D, Gebel J, Miller R, Kothari R, Brott T, Khoury J, et al. Incidence rates of first-ever ischemic stroke subtypes among blacks: a population-based study. Stroke 1999;30:2517-2522.
7. Jung KH, Lee SH, Kim BJ, Yu KH, Hong KS, Lee BC, et al. Secular trends in ischemic stroke characteristics in a rapidly developed country: results from the Korean Stroke Registry Study (secular trends in Korean stroke). Circ Cardiovasc Qual Outcomes 2012;5:327-334.
8. Syed NA, Khealani BA, Ali S, Hasan A, Akhtar N, Brohi H, et al. Ischemic stroke subtypes in Pakistan: the Aga Khan University Stroke Data Bank. J Pak Med Assoc 2003;53:584-588.
9. Tsai CF, Thomas B, Sudlow CL. Epidemiology of stroke and its subtypes in Chinese vs white populations: a systematic review. Neurology 2013;81:264-272.
10. Turin TC, Kita Y, Rumana N, Nakamura Y, Takashima N, Ichikawa M, et al. Ischemic stroke subtypes in a Japanese population: Takashima Stroke Registry, 1988-2004. Stroke 2010; 41:1871-1876.
11. Kubo M, Hata J, Doi Y, Tanizaki Y, Iida M, Kiyohara Y. Secular trends in the incidence of and risk factors for ischemic stroke and its subtypes in Japanese population. Circulation 2008;118: 2672-2678.
12. Qureshi AI, Mendelow AD, Hanley DF. Intracerebral haemorrhage. Lancet 2009;373:1632-1644.
13. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American heart association/American stroke association. Stroke 2011;42:2672-2713.
14. Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol 2013;12:483-497.
15. Lammie GA, Brannan F, Slattery J, Warlow C. Nonhypertensive cerebral small-vessel disease. An autopsy study. Stroke 1997;28: 2222-2229.
16. Meschia JF. Ischemic stroke as a complex genetic disorder. Se­min Neurol 2006;26:49-56.
17. Flossmann E, Schulz UG, Rothwell PM. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke 2004;35:212-227.
18. Polychronopoulos P, Gioldasis G, Ellul J, Metallinos IC, Lekka NP, Paschalis C, et al. Family history of stroke in stroke types and subtypes. J Neurol Sci 2002;195:117-122.
19. Jerrard-Dunne P, Cloud G, Hassan A, Markus HS. Evaluating the genetic component of ischemic stroke subtypes: a family history study. Stroke 2003;34:1364-1369.
20. Carmelli D, DeCarli C, Swan GE, Jack LM, Reed T, Wolf PA, et al. Evidence for genetic variance in white matter hyperinten­sity volume in normal elderly male twins. Stroke 1998;29: 1177-1181.
21. Atwood LD, Wolf PA, Heard-Costa NL, Massaro JM, Beiser A, D’Agostino RB, et al. Genetic variation in white matter hy­perintensity volume in the Framingham Study. Stroke 2004; 35:1609-1613.
22. Woo D, Sauerbeck LR, Kissela BM, Khoury JC, Szaflarski JP, Gebel J, et al. Genetic and environmental risk factors for intra­cerebral hemorrhage: preliminary results of a population-based study. Stroke 2002;33:1190-1195.
23. Tabor HK, Risch NJ, Myers RM. Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet 2002;3:391-397.
24. Zhang Z, Xu G, Liu D, Fan X, Zhu W, Liu X. Angiotensin-con­verting enzyme insertion/deletion polymorphism contributes to ischemic stroke risk: a meta-analysis of 50 case-control stud­ies. PLoS One 2012;7:e46495.
25. Paternoster L, Chen W, Sudlow CL. Genetic determinants of white matter hyperintensities on brain scans: a systematic as­sessment of 19 candidate gene polymorphisms in 46 studies in 19,000 subjects. Stroke 2009;40:2020-2026.
26. Peck G, Smeeth L, Whittaker J, Casas JP, Hingorani A, Sharma P. The genetics of primary haemorrhagic stroke, subarachnoid haemorrhage and ruptured intracranial aneurysms in adults. PLoS One 2008;3:e3691.
27. Biffi A, Sonni A, Anderson CD, Kissela B, Jagiella JM, Schmidt H, et al. Variants at APOE influence risk of deep and lobar in­tracerebral hemorrhage. Ann Neurol 2010;68:934-943.
28. Biffi A, Anderson CD, Jagiella JM, Schmidt H, Kissela B, Han­sen BM, et al. APOE genotype and extent of bleeding and out­come in lobar intracerebral haemorrhage: a genetic association study. Lancet Neurol 2011;10:702-709.
29. Maxwell SS, Jackson CA, Paternoster L, Cordonnier C, Thijs V, Al-Shahi Salman R, et al. Genetic associations with brain mi­crobleeds: Systematic review and meta-analyses. Neurology 2011;77:158-167.
30. Yamada M, Tsukagoshi H, Otomo E, Hayakawa M. Cerebral amyloid angiopathy in the aged. J Neurol 1987;234:371-376.
31. Pearson TA, Manolio TA. How to interpret a genome-wide as­sociation study. JAMA 2008;299:1335-1344.
32. Kubo M, Hata J, Ninomiya T, Matsuda K, Yonemoto K, Nakano T, et al. A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction. Nat Genet 2007;39: 212-217.
33. Serizawa M, Nabika T, Ochiai Y, Takahashi K, Yamaguchi S, Makaya M, et al. Association between PRKCH gene polymor­phisms and subcortical silent brain infarction. Atherosclerosis 2008;199:340-345.
34. Wu L, Shen Y, Liu X, Ma X, Xi B, Mi J, et al. The 1425G/A SNP in PRKCH is associated with ischemic stroke and cerebral hem­orrhage in a Chinese population. Stroke 2009;40:2973-2976.
35. Traylor M, Farrall M, Holliday EG, Sudlow C, Hopewell JC, Cheng YC, et al. Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol 2012;11: 951-962.
36. Bevan S, Traylor M, Adib-Samii P, Malik R, Paul NL, Jackson C, et al. Genetic heritability of ischemic stroke and the contri­bution of previously reported candidate gene and genomewide associations. Stroke 2012;43:3161-3167.
37. Debette S, Bis JC, Fornage M, Schmidt H, Ikram MA, Sigurds­son S, et al. Genome-wide association studies of MRI-defined brain infarcts: meta-analysis from the CHARGE Consortium. Stroke 2010;41:210-217.
38. Fornage M, Debette S, Bis JC, Schmidt H, Ikram MA, Dufouil C, et al. Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol 2011;69:928-939.
39. Woo D, Falcone GJ, Devan WJ, Brown WM, Biffi A, Howard TD, et al. Meta-analysis of genome-wide association studies identifies 1q22 as a susceptibility locus for intracerebral hemor­rhage. Am J Hum Genet 2014;94:511-521.
40. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mou­ton P, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996;383: 707-710.
41. Choi JC. Cerebral autosomal dominant arteriopathy with sub­cortical infarcts and leukoencephalopathy: a genetic cause of cerebral small vessel disease. J Clin Neurol 2010;6:1-9.
42. Chabriat H, Vahedi K, Iba-Zizen MT, Joutel A, Nibbio A, Nagy TG, et al. Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical in­farcts and leukoencephalopathy. Lancet 1995;346:934-939.
43. Dichgans M, Mayer M, Uttner I, Bruning R, Muller-Hocker J, Rungger G, et al. The phenotypic spectrum of CADASIL: clini­cal findings in 102 cases. Ann Neurol 1998;44:731-739.
44. Desmond DW, Moroney JT, Lynch T, Chan S, Chin SS, Mohr JP. The natural history of CADASIL: a pooled analysis of pre­viously published cases. Stroke 1999;30:1230-1233.
45. Choi JC, Song SK, Lee JS, Kang SY, Kang JH. Diversity of stroke presentation in CADASIL: study from patients harboring the predominant NOTCH3 mutation R544C. J Stroke Cerebrovasc Dis 2013;22:126-131.
46. Singhal S, Bevan S, Barrick T, Rich P, Markus HS. The influence of genetic and cardiovascular risk factors on the CADASIL phe­notype. Brain 2004;127:2031-2038.
47. Valenti R, Poggesi A, Pescini F, Inzitari D, Pantoni L. Psychiatric disturbances in CADASIL: a brief review. Acta Neurol Scand 2008;118:291-295.
48. Dichgans M, Petersen D. Angiographic complications in CA­DASIL. Lancet 1997;349:776-777.
49. Feuerhake F, Volk B, Ostertag CB, Jungling FD, Kassubek J, Orszagh M, et al. Reversible coma with raised intracranial pres­sure: an unusual clinical manifestation of CADASIL. Acta Neu­ropathol 2002;103:188-192.
50. Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bouss­er MG. Cadasil. Lancet Neurol 2009;8:643-653.
51. van den Boom R, Lesnik Oberstein SA, Ferrari MD, Haan J, van Buchem MA. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: MR imag­ing findings at different ages--3rd-6th decades. Radiology 2003; 229:683-690.
52. Chabriat H, Levy C, Taillia H, Iba-Zizen MT, Vahedi K, Joutel A, et al. Patterns of MRI lesions in CADASIL. Neurology 1998; 51:452-457.
53. O’Sullivan M, Jarosz JM, Martin RJ, Deasy N, Powell JF, Markus HS. MRI hyperintensities of the temporal lobe and external cap­sule in patients with CADASIL. Neurology 2001;56:628-634.
54. De Guio F, Vignaud A, Ropele S, Duering M, Duchesnay E, Chabriat H, et al. Loss of venous integrity in cerebral small ves­sel disease: a 7-T MRI study in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopa­thy (CADASIL). Stroke 2014;45:2124-2126.
55. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 1999; 284:770-776.
56. Joutel A, Andreux F, Gaulis S, Domenga V, Cecillon M, Battail N, et al. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin In­vest 2000;105:597-605.
57. Alva JA, Iruela-Arispe ML. Notch signaling in vascular morpho­genesis. Curr Opin Hematol 2004;11:278-283.
58. Tikka S, Mykkanen K, Ruchoux MM, Bergholm R, Junna M, Poyhonen M, et al. Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients. Brain 2009;132:933-939.
59. Schmidt H, Zeginigg M, Wiltgen M, Freudenberger P, Petrovic K, Cavalieri M, et al. Genetic variants of the NOTCH3 gene in the elderly and magnetic resonance imaging correlates of age-re­lated cerebral small vessel disease. Brain 2011;134:3384-3397.
60. Razvi SS, Davidson R, Bone I, Muir KW. The prevalence of ce­rebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) in the west of Scotland. J Neurol Neurosurg Psychiatry 2005;76:739-741.
61. Dong Y, Hassan A, Zhang Z, Huber D, Dalageorgou C, Markus HS. Yield of screening for CADASIL mutations in lacunar stroke and leukoaraiosis. Stroke 2003;34:203-205.
62. Hara K, Shiga A, Fukutake T, Nozaki H, Miyashita A, Yokoseki A, et al. Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. N Engl J Med 2009;360:1729-1739.
63. Fukutake T. Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): from discovery to gene identification. J Stroke Cerebrovasc Dis 2011;20:85-93.
64. Nozaki H, Nishizawa M, Onodera O. Features of cerebral auto­somal recessive arteriopathy with subcortical infarcts and leu­koencephalopathy. Stroke 2014;45:3447-3457.
65. Bianchi S, Di Palma C, Gallus GN, Taglia I, Poggiani A, Rosini F, et al. Two novel HTRA1 mutations in a European CARA­SIL patient. Neurology 2014;82:898-900.
66. Mendioroz M, Fernandez-Cadenas I, Del Rio-Espinola A, Rovi­ra A, Sole E, Fernandez-Figueras MT, et al. A missense HTRA1 mutation expands CARASIL syndrome to the Caucasian popu­lation. Neurology 2010;75:2033-2035.
67. Gould DB, Phalan FC, Breedveld GJ, van Mil SE, Smith RS, Schimenti JC, et al. Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly. Science 2005;308:1167-1171.
68. Gould DB, Phalan FC, van Mil SE, Sundberg JP, Vahedi K, Massin P, et al. Role of COL4A1 in small-vessel disease and hemorrhagic stroke. N Engl J Med 2006;354:1489-1496.
69. Sibon I, Coupry I, Menegon P, Bouchet JP, Gorry P, Burgelin I, et al. COL4A1 mutation in Axenfeld-Rieger anomaly with leu­koencephalopathy and stroke. Ann Neurol 2007;62:177-184.
70. Lanfranconi S, Markus HS. COL4A1 mutations as a mono­genic cause of cerebral small vessel disease: a systematic review. Stroke 2010;41:e513-518.
71. Emanuel BS, Sellinger BT, Gudas LJ, Myers JC. Localization of the human procollagen alpha 1(IV) gene to chromosome 13q34 by in situ hybridization. Am J Hum Genet 1986;38:38-44.
72. Kuo DS, Labelle-Dumais C, Gould DB. COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets. Hum Mol Genet 2012;21: R97-110.
73. Grand MG, Kaine J, Fulling K, Atkinson J, Dowton SB, Farber M, et al. Cerebroretinal vasculopathy. A new hereditary syndrome. Ophthalmology 1988;95:649-659.
74. Jen J, Cohen AH, Yue Q, Stout JT, Vinters HV, Nelson S, et al. Hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS). Neurology 1997;49:1322-1330.
75. Terwindt GM, Haan J, Ophoff RA, Groenen SM, Storimans CW, Lanser JB, et al. Clinical and genetic analysis of a large Dutch family with autosomal dominant vascular retinopathy, migraine and Raynaud’s phenomenon. Brain 1998;121 (Pt 2):303-316.
76. Ophoff RA, DeYoung J, Service SK, Joosse M, Caffo NA, Sand­kuijl LA, et al. Hereditary vascular retinopathy, cerebroretinal vasculopathy, and hereditary endotheliopathy with retinopathy, nephropathy, and stroke map to a single locus on chromosome 3p21.1-p21.3. Am J Hum Genet 2001;69:447-453.
77. Richards A, van den Maagdenberg AM, Jen JC, Kavanagh D, Bertram P, Spitzer D, et al. C-terminal truncations in human 3’-5’ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nat Genet 2007;39: 1068-1070.
78. Crow YJ, Hayward BE, Parmar R, Robins P, Leitch A, Ali M, et al. Mutations in the gene encoding the 3’-5’ DNA exonuclease TREX1 cause Aicardi-Goutieres syndrome at the AGS1 locus. Nat Genet 2006;38:917-920.
79. Brady RO. Enzymatic abnormalities in diseases of sphingolipid metabolism. Clin Chem 1967;13:565-577.
80. Houge G, Skarbovik AJ. Fabry disease--a diagnostic and thera­peutic challenge. Tidsskr Nor Laegeforen 2005;125:1004-1006.
81. Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA 1999;281:249-254.
82. Shi Q, Chen J, Pongmoragot J, Lanthier S, Saposnik G. Preva­lence of Fabry disease in stroke patients--a systematic review and meta-analysis. J Stroke Cerebrovasc Dis 2014;23:985-992.
83. Mitsias P, Levine SR. Cerebrovascular complications of Fabry’s disease. Ann Neurol 1996;40:8-17.
84. Crutchfield KE, Patronas NJ, Dambrosia JM, Frei KP, Banerjee TK, Barton NW, et al. Quantitative analysis of cerebral vascu­lopathy in patients with Fabry disease. Neurology 1998;50: 1746-1749.
85. Moore DF, Ye F, Schiffmann R, Butman JA. Increased signal in­tensity in the pulvinar on T1-weighted images: a pathogno­monic MR imaging sign of Fabry disease. AJNR Am J Neurora­diol 2003;24:1096-1101.
86. Kraft P, Wacholder S, Cornelis MC, Hu FB, Hayes RB, Thom­as G, et al. Beyond odds ratios--communicating disease risk based on genetic profiles. Nat Rev Genet 2009;10:264-269.
87. Malik R, Bevan S, Nalls MA, Holliday EG, Devan WJ, Cheng YC, et al. Multilocus genetic risk score associates with ischemic stroke in case-control and prospective cohort studies. Stroke 2014;45:394-402.
88. Ibrahim-Verbaas CA, Fornage M, Bis JC, Choi SH, Psaty BM, Meigs JB, et al. Predicting stroke through genetic risk functions: the CHARGE Risk Score Project. Stroke 2014;45:403-412.
89. El Dib RP, Nascimento P, Pastores GM. Enzyme replacement therapy for Anderson-Fabry disease. Cochrane Database Syst Rev 2013;2:CD006663.
90. Park JH, Wacholder S, Gail MH, Peters U, Jacobs KB, Chanock SJ, et al. Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat Genet 2010;42:570-575.
91. Battey TW, Valant V, Kassis SB, Kourkoulis C, Lee C, Anderson CD, et al. Recommendations From the International Stroke Genetics Consortium, Part 2: Biological Sample Collection and Storage. Stroke 2015;46:285-290.
92. Majersik JJ, Cole JW, Golledge J, Rost NS, Chan YF, Gurol ME, et al. Recommendations From the International Stroke Genet­ics Consortium, Part 1: Standardized Phenotypic Data Collec­tion. Stroke 2015;46:279-284.
93. Wetterstrand K. DNA Sequencing Costs: Data from the NH­GRI Genome Sequencing Program (GSP) Available at: www.genome.gov/sequencingcosts. Accessed. December 11, 2014.
94. Joutel A, Faraci FM. Cerebral small vessel disease: insights and opportunities from mouse models of collagen IV-related small vessel disease and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke 2014; 45:1215-1221.